Shared Research logo
  • Home
  • All Companies
    All Companies
    Companies
    Recently viewed
    Browse companies...
  • English
    日本語
  • Log in
  • Sign up
Overview
My Comments
My Notes
SanBio

SanBio 4592

サンバイオ
SanBio Company Limited
Recent Updates
2023-05-12
Full-year FY01/23 report update
2023-03-16
Full-year FY01/23 flash update
2022-12-15
Q3 FY01/23 flash update
Get in touch
Address:Seiroka Tower 13F 8-1 Akashicho Chuo-ku Tokyo 104-0044
Website:https://www.sanbio.com/en/ir/
Summary
SanBio is a biotechnology company that develops regenerative cell medicines to restore nerve function lost due to disease or injury. Many companies are involved in regenerative medicine, including those involved in drug discovery and development, those specializing in production, and those selling related equipment and services. SanBio develops new drugs (cell medicines) that use allogeneic transplantation (see figure below). In terms of clinical development, SanBio is the most advanced company using regenerative cell medicines to treat central nervous system disorders. The company develops drug candidates internally through discovery and early clinical development, and then out-licenses the products to larger, multinational pharmaceutical companies.
Key dates
2016-06-08
Coverage initiation